These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 30607469)
41. Astrocyte Elevated Gene 1 (AEG-1) Acts as a Promoter Gene in Clear Cell Renal Cell Carcinoma Cell Growth and Metastasis. Yu DP; Zhou Y Med Sci Monit; 2018 Nov; 24():8213-8223. PubMed ID: 30431025 [TBL] [Abstract][Full Text] [Related]
42. CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities. Xie J; Yuan Y; Liu Z; Xiao Y; Zhang X; Qin C; Sheng Z; Xu T; Wang X Clin Transl Oncol; 2014 Apr; 16(4):402-9. PubMed ID: 23907292 [TBL] [Abstract][Full Text] [Related]
43. Euxanthone suppresses tumor growth and metastasis in colorectal cancer via targeting CIP2A/PP2A pathway. Wang N; Zhou F; Guo J; Zhu H; Luo S; Cao J Life Sci; 2018 Sep; 209():498-506. PubMed ID: 30144452 [TBL] [Abstract][Full Text] [Related]
44. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway. Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137 [TBL] [Abstract][Full Text] [Related]
45. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1. Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327 [TBL] [Abstract][Full Text] [Related]
46. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation. Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647 [TBL] [Abstract][Full Text] [Related]
47. Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells. Li J; Wu DD; Zhang JX; Wang J; Ma JJ; Hu X; Dong WG World J Gastroenterol; 2018 May; 24(17):1901-1910. PubMed ID: 29740205 [TBL] [Abstract][Full Text] [Related]
48. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling. Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891 [TBL] [Abstract][Full Text] [Related]
49. YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway. Li W; Ye K; Li X; Liu X; Peng M; Chen F; Xiong W; Wang Y; Zhu L J Exp Clin Cancer Res; 2022 Aug; 41(1):250. PubMed ID: 35974388 [TBL] [Abstract][Full Text] [Related]
50. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells. Xu L; Zhang Y; Gao M; Wang G; Fu Y Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060 [TBL] [Abstract][Full Text] [Related]
51. Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Morikawa T; Sugiyama A; Kume H; Ota S; Kashima T; Tomita K; Kitamura T; Kodama T; Fukayama M; Aburatani H Clin Cancer Res; 2007 Oct; 13(19):5703-9. PubMed ID: 17908959 [TBL] [Abstract][Full Text] [Related]
52. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets. Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374 [TBL] [Abstract][Full Text] [Related]
53. A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma. Salama MF; Carroll B; Adada M; Pulkoski-Gross M; Hannun YA; Obeid LM FASEB J; 2015 Jul; 29(7):2803-13. PubMed ID: 25805832 [TBL] [Abstract][Full Text] [Related]
54. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma. Chen SL; Huang QS; Huang YH; Yang X; Yang MM; He YF; Cao Y; Guan XY; Yun JP Theranostics; 2020; 10(20):9186-9199. PubMed ID: 32802186 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of MicroRNA-381 Promotes Tumor Cell Growth and Chemoresistance in Clear-Cell Renal Cell Carcinoma. Chan Y; Yu Y; Wang G; Wang C; Zhang D; Wang X; Wang Z; Jian W; Zhang C Med Sci Monit; 2019 Jul; 25():5181-5190. PubMed ID: 31299041 [TBL] [Abstract][Full Text] [Related]
56. Combining α-Hederin with cisplatin increases the apoptosis of gastric cancer in vivo and in vitro via mitochondrial related apoptosis pathway. Deng H; Ma J; Liu Y; He P; Dong W Biomed Pharmacother; 2019 Dec; 120():109477. PubMed ID: 31562979 [TBL] [Abstract][Full Text] [Related]
57. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma. Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393 [TBL] [Abstract][Full Text] [Related]
58. MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma. Zhao Y; Ling Z; Hao Y; Pang X; Han X; Califano JA; Shan L; Gu X Oncotarget; 2017 Apr; 8(15):25005-25020. PubMed ID: 28212569 [TBL] [Abstract][Full Text] [Related]
59. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling. Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610 [TBL] [Abstract][Full Text] [Related]